Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/options/2023/07/06/3-stocks-moving-today-crbu-meta-afrm

7/6/2023 2:52 PM

Here are three of today's notable movers, as the broader market takes a tumble following this morning's flood of economic data. Caribou Biosciences Inc (NASDAQ:CRBU) is gapping higher on the charts ...

Fed Decision, Earnings Highlight First Week of May

https://www.schaeffersresearch.com/content/news/2023/04/27/fed-decision-earnings-highlight-first-week-of-may

4/27/2023 1:00 PM

Next week will be packed with more quarterly reports, as earnings season remains in full swing. The start of the month will also bring a slew of economic news, with the latest Fed interest rate decisi...

Why You Should Trade Straddles Right Now

https://www.schaeffersresearch.com/content/bgs/2023/03/17/why-you-should-trade-straddles-right-now

3/17/2023 10:26 AM

Subscribers to Chart of the Week received this commentary on Sunday, March 12. Earlier this month, subscribers to our Volatility Trader (VT) service scored an 80% profit on a Pfizer Inc (NYSE:PFE)...

Seagen Stock Boosted on Billion-Dollar Buyout

https://www.schaeffersresearch.com/content/news/2023/03/13/seagen-stock-boosted-on-billion-dollar-buyout

3/13/2023 11:41 AM

Seagen Inc (NASDAQ:SGEN) stock is soaring today, after news that Pfizer (PFE) is acquiring the company for roughly $43 billion, expanding its access to cancer treatment. At last glance, SGEN was up 15...

Pfizer Shares Dismal Sales Outlook Despite Record Revenue

https://www.schaeffersresearch.com/content/news/2023/01/31/pfizer-shares-dismal-sales-outlook-despite-record-revenue

1/31/2023 10:18 AM

Pfizer Inc. (NYSE:PFE) is down 0.8% to trade at $43.22, despite reporting better-than-anticipated fourth-quarter earnings of $1.14 per share, in addition to record revenue of $100.3 billion in 2022....

PEOPLE ALSO SEARCH FOR

-intraday-options-activity